Economic evaluation of interventions in endocrinology.
This article provides a review of methods for conducting cost-effectiveness, cost-utility, and cost-benefit studies. Economic evaluations of interventions designed to improve outcomes of patients with diabetes and osteoporosis are reviewed, and key issues for future research are discussed. The role of cost-effectiveness analysis in reimbursement decision making at the public and private levels is explored.
Taylor
T N
TN
Division of Clinical and Administrative Pharmacy, College of Pharmacy, University of Iowa, Iowa City, USA.
Chrischilles
E A
EA
D003362:Cost-Benefit Analysis; D003365:Costs and Cost Analysis; D003920:Diabetes Mellitus / Q000191:economics / Q000628:therapy; D003928:Diabetic Nephropathies / Q000191:economics / Q000628:therapy; D003930:Diabetic Retinopathy / Q000191:economics / Q000628:therapy; D004700:Endocrine System Diseases / Q000191:economics / Q000628:therapy; D004704:Endocrinology / Q000191:economics*; D006801:Humans; D010024:Osteoporosis / Q000191:economics / Q000628:therapy